Australia markets closed

23andMe Holding Co. (ME)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4829+0.0129 (+2.74%)
At close: 04:00PM EDT
0.4840 +0.00 (+0.23%)
After hours: 04:25PM EDT
Full screen
Loading interactive chart…
  • GlobeNewswire

    23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel

    SOUTH SAN FRANCISCO, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading preventive health and therapeutics company, and Nightingale Health Plc, a pioneer in biomarker testing and risk prediction, today announced a strategic collaboration to pilot Nightingale Health’s clinically-validated and cost-effective blood metabolomics panel with a cohort of 23andMe members. Nightingale’s Remote Health Check accurately measures dozens of biomarkers from a single blood sam

  • GlobeNewswire

    23andMe Launches New Genetic Report on Bipolar Disorder

    Provides 23andMe+ Premium members with insight into their likelihood of developing the serious mental health illness based on thousands of genetic variantsSOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, today released a new genetic Bipolar Disorder report (Powered by 23andMe Research) for 23andMe+ Premium members, informing them if they are at higher likelihood for being diagnosed with the co

  • GlobeNewswire

    23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community

    Study aims to fill research gap and empower people through access to information about their healthSUNNYVALE, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading genetic health and biopharmaceutical company, and the Colorectal Cancer Alliance (Alliance), the largest nonprofit organization dedicated to ending colorectal cancer, announced a collaboration to help advance research on colorectal cancer in the Black/African American community. The Genetic In